Carter's Stock Price and Value Analysis

Should you buy Carter's stock? (NYSE:CRI). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company has stable growth.
  • This company is making money at a modest rate.
  • This company has a low dividend yield.
  • This stock looks overpriced.

Inside the CRI Numbers

CRI Price
(Carter's stock price per share)
[?] CRI Fair Price
(based on intrinsic value)
[?] CRI Safety Price (based on a variable margin of safety) $38.16
[?] PE Ratio versus Sector 22% higher than other Consumer Goods stocks
[?] PE Ratio versus Industry 25% lower than other Unknown stocks
[?] Cash Yield 5.85%
[?] Free Cash Flow Jitter 19%
[?] Dividend Yield 2%
Shares Shorted 2,459,614

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 2,459,614 shares shorted. With 41,233,660 shares available for purchase and an average trading volume over the past 10 trading days of 485,820, it would take at least 5.063 days for all of the short holders to cover their shorts.

Is Carter's Stock on Sale?

We believe that Carter's may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Carter's looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy CRI Stock?

Does Carter's have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.